WuXi PharmaTech Expands Genomics with Illumina Sequencer

WuXi PharmaTech, the largest China-US CRO, has purchased an Illumina HiSeq X Ten sequencing system for the WuXi Genome Center. The machine costs at least $10 million and is designed to produce full-coverage individual genomes for $1,000. WuXi said Illumina’s latest and most powerful sequencer would expand its services to population genome scale sequencing. Currently, the company offers target panel, exome and transcriptome scale sequencing. More details.... Stock Symbols: (NYSE: WX) (NSDQ: ILMN) Share this with colleagues: // //